EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2

Linchao Lu, Shweta Varshney, Youxi Yuan, Hua-Xing Wei, Ankit Tanwar, Subha Sundaram, Mohd Nauman, Robert S Haltiwanger, Pamela Stanley

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Linchao Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department Cell Biology, Albert Einstein College of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Fucose, Monosaccharide Transport Proteins, Nucleotide Transport Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Slc35c1 encodes an antiporter that transports GDP-fucose into the Golgi and returns GMP to the cytoplasm. The closely related gene Slc35c2 encodes a putative GDP-fucose transporter and promotes Notch fucosylation and Notch signaling in cultured cells. Here, we show that HEK293T cells lacking SLC35C1 transferred reduced amounts of O-fucose to secreted epidermal growth factor-like repeats from NOTCH1 or secreted thrombospondin type I repeats from thrombospondin 1. However, cells lacking SLC35C2 did not exhibit reduced fucosylation of these epidermal growth factor-like repeats or thrombospondin type I repeats. To investigate SLC35C2 functions in vivo, WW6 embryonic stem cells were targeted for Slc35c2. Slc35c2[-/-] mice were viable and fertile and exhibited no evidence of defective Notch signaling during skeletal or T cell development. By contrast, mice with inactivated Slc35c1 exhibited perinatal lethality and marked skeletal defects in late embryogenesis, typical of defective Notch signaling. Compound Slc35c1[-/-]Slc35c2[-/-] mutants were indistinguishable in skeletal phenotype from Slc35c1[-/-] embryos and neonates. Double mutants did not exhibit the exacerbated skeletal defects predicted if SLC35C2 was functionally important for Notch signaling in vivo. In addition, NOTCH1 immunoprecipitated from Slc35c1[-/-]Slc35c2[-/-] neonatal lung carried fucose detected by binding of Aleuria aurantia lectin. Given that the absence of both SLC35C1, a known GDP-fucose transporter, and SLC35C2, a putative GDP-fucose transporter, did not lead to afucosylated NOTCH1 nor to the severe Notch signaling defects and embryonic lethality expected if all GDP-fucose transport were abrogated, at least one more mechanism of GDP-fucose transport into the secretory pathway must exist in mammals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FucoseMonosaccharide Transport ProteinsNucleotide Transport ProteinsAnimalsFemaleHumansMicePregnancyEpidermal Growth FactorHEK293 CellsNeoplasm ProteinsThrombospondinsMice, KnockoutReceptor, Notch1Signal Transduction

Stichwörter der Autor:innen

GDP-fucose transporterNotch signalingO-fucose glycansgene deletionskeletal development

Substanzen

Epidermal Growth FactorFucoseMonosaccharide Transport ProteinsNeoplasm ProteinsNucleotide Transport ProteinsSLC35C1 protein, humanSLC35C2 protein, humanThrombospondinsNOTCH1 protein, humanReceptor, Notch1

Autor:innen und Institutionen

  • Department Cell Biology, Albert Einstein College of Medicine, New York, New York, USA.
  • Department of Biochemistry and Molecular Biology, Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, USA.
  • Department Cell Biology, Albert Einstein College of Medicine, New York, New York, USA. Electronic address: pamela.stanley@einsteinmed.edu.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of General Medical Sciences
  • Georgia Research Alliance
  • National Cancer Institute

Zitieren

APA

Lu, L., Varshney, S., Yuan, Y., Wei, H. X., Tanwar, A., Sundaram, S., Nauman, M., Haltiwanger, R. S., & Stanley, P. (2023). In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105406

Vancouver

Lu L, Varshney S, Yuan Y, Wei HX, Tanwar A, Sundaram S, et al. In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105406

BibTeX
@article{Lu2023,
  author = {Lu, Linchao and Varshney, Shweta and Yuan, Youxi and Wei, Hua-Xing and Tanwar, Ankit and Sundaram, Subha and Nauman, Mohd and Haltiwanger, Robert S and Stanley, Pamela},
  title = {In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105406}
}
Kostenlos starten →